Publications by authors named "Joyce Ford"

Claim this Profile
A
A phase 1, randomized study to assess the pharmacokinetic comparability of siltuximab derived from two different cell lines in healthy subjects.
Chao Xu, Chao Han, Joseph Marini, Joyce Ford, Stanley Marciniak

Clin Pharmacol Drug Dev· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of infliximab in children with moderate-to-severe ulcerative colitis: results from a randomized, multicenter, open-label, phase 3 study.
Omoniyi J Adedokun, Zhenhua Xu, Lakshmi Padgett, Marion Blank, Jewel Johanns, Joyce Ford

Inflamm Bowel Dis· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of golimumab in healthy Chinese subjects following a single subcutaneous administration in a randomized phase I trial.
Yanli Zhuang, Sally Lyn, Yuan Lv, Zhenhua Xu, Esther Bouman-Thio, Joyce A Ford

Clin Drug Investig· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of sirukumab following a single subcutaneous administration to healthy Japanese and Caucasian subjects.
Yanli Zhuang, Zhenhua Xu, Dick E de Vries, Qingmin Wang, Akira Shishido, Joyce A Ford

Int J Clin Pharmacol Ther· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Golimumab pharmacokinetics after repeated subcutaneous and intravenous administrations in patients with rheumatoid arthritis and the effect of concomitant methotrexate: an open-label, randomized study.
Yanli Zhuang, Zhenhua Xu, Bart Frederick, Dick E de Vries, Joyce A Ford

Clin Ther· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of racial differences in the pharmacokinetics of subcutaneous golimumab in healthy Japanese and Caucasian male subjects.
Jie Ling, Sally Lyn, Zhenhua Xu, Meguru Achira, Esther Bouman-Thio, Joyce Ford

J Clin Pharmacol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis.
Adedigbo A Fasanmade, Omoniyi J Adedokun, Joyce Ford, Danika Hernandez, Jewel Johanns

Eur J Clin Pharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery.
Sunanda Kane, Joyce Ford, Russell Cohen, Carrie Wagner

J Clin Gastroenterol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of infliximab in patients with ankylosing spondylitis.
Zhenhua Xu, Kathleen Seitz, Adedigbo Fasanmade, Joyce Ford, Paul Williamson

J Clin Pharmacol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients.
Aminah Jatoi, James R Jett, Jeff Sloan, Paul Novotny, Joyce Ford

Support Care Cancer· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis